A large quantity of serum fibrotic markers has been found as possible biomarkers for PID, and our study showed that serum MMP-9, TGF-β1 and ICAM-1 levels were markedly higher in PID patients with pelvic adhesion. Here, MMP9 is linked to pelvic inflammatory disease.